Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duyiwei capsules for knee osteoarthritis
ChiCTR2400083198Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing celecoxib + Duyiwei capsule with Control: celecoxib + Duyiwei capsule placebo (2 arms). Primary endpoints: Visual analogue pain score (VAS) and Safety index. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
duyiwei
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400083198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083198.